Fox Run Management, L.L.C. Lexicon Pharmaceuticals, Inc. Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 17, 2019	SELL	$5.35 - $7.11 $70,175 - $93,261	-13,117 Closed	0 $0
Q1 2019 Oct 17, 2019	SELL	$4.36 - $7.94 $22,161 - $40,359	-5,083 Reduced 27.93%	13,117 $73,000
Q4 2018 Jan 15, 2019	SELL	$6.15 - $10.51 $43,105 - $73,664	-7,009 Reduced 27.8%	18,200 $121,000
Q3 2018 Oct 05, 2018	SELL	$10.32 - $13.06 $134,841 - $170,641	-13,066 Reduced 34.14%	25,209 $269,000
Q2 2018 Jul 17, 2018	SELL	$7.8 - $13.69 $54,584 - $95,802	-6,998 Reduced 15.46%	38,275 $459,000
Q1 2018 Apr 17, 2018	BUY	$7.86 - $11.39 $355,845 - $515,659	45,273 New	45,273 $388,000
Q4 2017 Jan 18, 2018	SELL	$8.77 - $12.28 $268,362 - $375,768	-30,600 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$12.17 - $16.3 $372,402 - $498,780	30,600	30,600 $376,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.